CENTRAL LIBRARY

Welcome to Online Public Access Catalogue (OPAC)

Polypharmacology in drug discovery / (Record no. 11697)

MARC details
000 -LEADER
fixed length control field 07179cam a2200961Ia 4500
001 - CONTROL NUMBER
control field ocn779410061
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20171224113852.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu---unuuu
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120306s2012 njua ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency N$T
Language of cataloging eng
Description conventions pn
Transcribing agency N$T
Modifying agency UIU
-- DG1
-- YDXCP
-- CDX
-- IUL
-- OCLCQ
-- MYG
-- E7B
-- COO
-- NLGGC
-- OCLCF
-- RECBK
-- NLE
-- MHW
-- IDEBK
-- OCLCQ
-- D6H
-- OCLCQ
-- AZK
019 ## -
-- 784124194
-- 811493986
-- 839336010
-- 860514925
-- 898985525
-- 961529870
-- 962708756
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781118098141
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1118098145
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781118098127
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1118098129
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781280589324
Qualifying information (MyiLibrary)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1280589329
Qualifying information (MyiLibrary)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781118098134
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1118098137
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9780470590904
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 0470590904
028 01 - PUBLISHER NUMBER
Publisher number EB00062625
Source Recorded Books
029 1# - (OCLC)
OCLC library identifier AU@
System control number 000049014066
029 1# - (OCLC)
OCLC library identifier DEBBG
System control number BV042794916
029 1# - (OCLC)
OCLC library identifier DEBBG
System control number BV043394309
029 1# - (OCLC)
OCLC library identifier DKDLA
System control number 820120-katalog:000600378
029 1# - (OCLC)
OCLC library identifier NLGGC
System control number 340803193
029 1# - (OCLC)
OCLC library identifier NZ1
System control number 14976855
029 1# - (OCLC)
OCLC library identifier ZWZ
System control number 17893285X
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)779410061
Canceled/invalid control number (OCoLC)784124194
-- (OCoLC)811493986
-- (OCoLC)839336010
-- (OCoLC)860514925
-- (OCoLC)898985525
-- (OCoLC)961529870
-- (OCoLC)962708756
037 ## - SOURCE OF ACQUISITION
Stock number 10.1002/9781118098141
Source of stock number/acquisition Wiley InterScience
Note http://www3.interscience.wiley.com
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM301.25
Item number .P65 2012eb
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 744
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 023000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 058170
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 071000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 072000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.19
Edition number 23
084 ## - OTHER CLASSIFICATION NUMBER
Classification number 44.42
Source of number bcl
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Polypharmacology in drug discovery /
Statement of responsibility, etc edited by Jens-Uwe Peters.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Hoboken, N.J. :
Name of publisher, distributor, etc Wiley,
Date of publication, distribution, etc ©2012.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xxiii, 510 pages) :
Other physical details illustrations
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
347 ## -
-- data file
-- rda
380 ## -
-- Bibliography
520 ## - SUMMARY, ETC.
Summary, etc "Covers the two-sided nature of polypharmacology--its contribution to adverse drug reactions and its benefit in certain therapeutic drug classes. Addresses the important topic of polypharmacology in drug discovery, a subject that has not been thoroughly covered outside of scattered journal articles. Overviews state-of-the-art approaches and developments to help readers understand concepts and issues related to polypharmacology."--
-- Provided by publisher.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Frontmatter -- Color Plates -- Introduction: The Case for Polypharmacology / Andrew L Hopkins -- Polypharmacology: A Safety Concern in Drug Discovery. The Relevance of Off-Target Polypharmacology / Bruce D Car -- Screening for Safety-Relevant Off-Target Activities / Laszlo Urban, Steven Whitebread, Jacques Hamon, Dmitri Mikhailov, Kamal Azzaoui -- Pharmacological Promiscuity and Molecular Properties / Jens-Uwe Peters -- Kinases as Antitargets in Genotoxicity / Stephan Kirchner -- Activity at Cardiovascular Ion Channels: A Key Issue for Drug Discovery / Ian M Bell, Mark T Bilodeau, Armando A Lagrutta -- Prediction of Side Effects Based on Fingerprint Profiling and Data Mining / Jacques Migeon -- Polypharmacology: An Opportunity for Drug Discovery. Polypharmacological Drugs: ₃Magic Shotguns₄ for Psychiatric Diseases / Wesley K Kroeze, Bryan L Roth -- Polypharmacological Kinase Inhibitors: New Hopes for Cancer Therapy / Annalisa Petrelli -- Polypharmacology as an Emerging Trend in Antibacterial Discovery / Lynn L Silver -- A ₃Magic Shotgun₄ Perspective on Anticonvulsant Mechanisms / Matt T Bianchi, Kathy Chuang -- Selective Optimization of Side Activities (SOSA): A Promising way for Drug Discovery / Thierry Langer, Camille-Georges Wermuth -- Selected Approaches to Polypharmacological Drug Discovery. Selective Multitargeted Drugs / Richard Morphy -- Computational Multitarget Drug Discovery / Jeremy A Horst, Adrian Laurenzi, Brady Bernard, Ram Samudrala -- Behavior-Based Screening as an Approach to Polypharmacological Ligands / Dani Brunner, Vadim Alexandrov, Barbara Caldarone, Taleen Hanania, David Lowe, Jeff Schneider, Jayaraman Chandrasekhar -- Multicomponent Therapeutics / Alexis A Borisy, Grant R Zimmermann, Joseph Leh̀r -- Case Studies. Discovery of Sunitinib as a Multitarget Treatment of Cancer / Catherine Delbaldo, Camelia Colichi, Marie-Paule Sablin, Chantal Dreyer, Bertrand Billemont, Sandrine Faivre, Eric Raymond -- Antipsychotics / Claus Riemer -- Triple-Uptake Inhibitors (Broad-Spectrum Antidepressants) / Phil Skolnick -- Therapeutic Potential of Small Molecules Modulating the Cyclooxygenase₆5-Lipoxygenase Pathway / Wolfgang Albrecht, Stefan Laufer -- Drug Research Leading to Imatinib and beyond to Nilotinib / Paul W Manley, Jorg Zimmermann -- Towards Antimalarial Hybrid Drugs / Bernard Meunier -- Multitargeted Drugs for Treatment of Alzheimer's Disease / Andrea Cavalli, Maria Laura Bolognesi -- Carbonic Anhydrases: Off Targets, Add-On Activities, or Emerging Novel Targets? / Claudiu T Supuran -- Index.
520 ## - SUMMARY, ETC.
Summary, etc "An essential outline of the main facets of polypharmacology in drug discovery research. Extending drug discovery opportunities beyond the "one drug, one target" philosophy, a polypharmacological approach to the treatment of complex diseases is emerging as a hot topic in both industry and academic research. Polypharmacology in Drug Discovery presents an overview of the various facets of polypharmacology and how it can be applied as an innovative concept for developing medicines for treating bacterial infections, epilepsy, cancer, psychiatric disorders, and more."--
-- Provided by publisher.
588 0# -
-- Print version record.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug development.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Toxicology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacology.
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medical.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Drug Guides.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Nursing
-- Pharmacology.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacology.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacy.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug development.
Source of heading or term fast
-- (OCoLC)fst00898670
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Toxicology.
Source of heading or term fast
-- (OCoLC)fst00898958
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacology.
Source of heading or term fast
-- (OCoLC)fst01060259
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug Discovery.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug Toxicity.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical Preparations
General subdivision chemistry.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Peters, Jens-Uwe.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Print version:
Title Polypharmacology in drug discovery.
Place, publisher, and date of publication Hoboken, N.J. : Wiley, ©2011
International Standard Book Number 9780470590904
Record control number (DLC) 2011052324
-- (OCoLC)714728070
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://onlinelibrary.wiley.com/book/10.1002/9781118098141">http://onlinelibrary.wiley.com/book/10.1002/9781118098141</a>
Public note Wiley Online Library
938 ## -
-- Coutts Information Services
-- COUT
-- 22302820
938 ## -
-- ebrary
-- EBRY
-- ebr10630573
938 ## -
-- EBSCOhost
-- EBSC
-- 437638
938 ## -
-- Ingram Digital eBook Collection
-- IDEB
-- 361915
938 ## -
-- Recorded Books, LLC
-- RECE
-- rbeEB00062625
938 ## -
-- YBP Library Services
-- YANK
-- 7574546
938 ## -
-- YBP Library Services
-- YANK
-- 5559500
938 ## -
-- YBP Library Services
-- YANK
-- 12670246
994 ## -
-- 92
-- DG1

No items available.


Khulna University of Engineering & Technology

Funded by: HEQEP, UGC, Bangladesh